Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial updates on an antifungal showing safety, efficacy, and pharmacokinetics in patients undergoing chemotherapy (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: COMPLETED